Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Chimerix Inc (CMRX)

2.82   0.09 (3.3%) 10-24 14:12
Open: 2.72 Pre. Close: 2.73
High: 2.86 Low: 2.69
Volume: 245,787 Market Cap: 186M
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Durham, North Carolina and currently employs 82 full-time employees. The firm is focused on discovering, developing and commercializing medicines that address unmet medical needs. Its lead compound, brincidofovir, is in development as an oral and intravenous (IV) formulation for the prevention and treatment of deoxyribonucleic acid (DNA) viruses, including smallpox, adenoviruses (AdV), and the human herpesviruses. The company is also advancing the development of CMX521 for the treatment and prevention of norovirus. In addition, the Company has an active discovery program focusing on viral targets for which limited or no therapies are available. Brincidofovir is an investigational oral nucleotide analog that has shown spectrum antiviral activity against all five families of double-stranded deoxyribonucleic acid (dsDNA) viruses that affect humans. Oral and IV formulations of brincidofovir are in development, both of which deliver the active antiviral directly to the site of viral replication.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.863 - 2.874 2.874 - 2.886
Low: 2.661 - 2.673 2.673 - 2.686
Close: 2.798 - 2.817 2.817 - 2.839

Technical analysis

as of: 2020-10-23 4:42:05 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.71     One year: 4.34
Support: Support1: 2.72    Support2: 2.43
Resistance: Resistance1: 3.18    Resistance2: 3.71
Pivot: 2.83
Moving Average: MA(5): 2.79     MA(20): 2.75
MA(100): 2.96     MA(250): 2.38
MACD: MACD(12,26): 0.03     Signal(9): 0.03
Stochastic oscillator: %K(14,3): 42.65     %D(3): 44.44
RSI: RSI(14): 52.39
52-week: High: 3.89  Low: 1.19  Change(%): 112.0
Average Vol(K): 3-Month: 44613  10-Days: 33459

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CMRX has closed above bottom band by 48.5%. Bollinger Bands are 15.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 19 Oct 2020
Should Chimerix Inc (CMRX) Stock be in Your Portfolio? - InvestorsObserver

Fri, 09 Oct 2020
JP Morgan lifts Chimerix Inc. [CMRX] price estimate. Who else is bullish? - The DBT News

Thu, 08 Oct 2020
What Happens Next To Chimerix, Inc. (CMRX) After That 19.84% Rise - Stocks Register

Thu, 08 Oct 2020
Is Chimerix Inc. (CMRX) a Keeper? - The News Heater

Wed, 07 Oct 2020
Should You Buy Chimerix Inc (CMRX) in Biotechnology Industry? - InvestorsObserver

Thu, 24 Sep 2020
How Will the Market React to Chimerix Inc (CMRX) Stock Getting a Bullish Rating - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 62
Shares Float (M) 44
% Held by Insiders 17.96
% Held by Institutions 56.31
Shares Short (K) 851
Shares Short P. Month (K) 1,060

Stock Financials

EPS -1.603
EPS Est This Year -1.630
EPS Est Next Year -1.850
Book Value (p.s.) 1.500
Profit Margin
Operating Margin -311.35
Return on Assets (ttm) -16.7
Return on Equity (ttm) -80.6
Qtrly Rev. Growth -2.5
Gross Profit (p.s.) -0.418
Sales Per Share 0.183
EBITDA (p.s.) -0.561
Qtrly Earnings Growth
Operating Cash Flow (M) -64
Levered Free Cash Flow (M) -23

Stock Valuations

PE Ratio -1.76
PEG Ratio
Price to Book value 1.88
Price to Sales 15.43
Price to Cash Flow -2.73

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.